Dosage regimen of an S1P receptor modulator

  • US 10,543,179 B2
  • Filed: 05/23/2018
  • Issued: 01/28/2020
  • Est. Priority Date: 09/29/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating relapsing remitting multiple sclerosis in a patient in need thereof, the method comprising:

  • (a) identifying a patient at risk of contracting infection caused by varicella zoster virus by testing said patient for a history of infection caused by varicella zoster virus,(b) vaccinating the patient at risk of contracting infection caused by varicella zoster virus, and(c) administering orally fingolimod or a pharmaceutically acceptable salt thereof to said patient at a daily dosage of 0.5 mg,thereby limiting the risk of infection caused by varicella zoster virus.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×